BioSpace News Archive

Press Releases

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results

October 15, 2024
·
6 min read
Press Releases

Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer

October 15, 2024
·
9 min read
Press Releases

Thryv Therapeutics Receives Positive Top-Line Results from Wave I Part 2 Clinical Study in Long QT Syndrome Type 2 and Type 3 Patients

October 15, 2024
·
3 min read
Press Releases

Monument Therapeutics Secures £1M Investment to Fund Its Schizophrenia Programme And Drive Next Stage of Growth

October 15, 2024
·
2 min read
Press Releases

Mid-Atlantic BioTherapeutics, Inc. Launches $5 Million Regulation D 506(c) Funding Round to Support Clinical Program Acceleration and Expand the Company’s Global Reach and Market Presence

October 15, 2024
·
5 min read
Press Releases

Triumvira Immunologics Announces Publication Demonstrating the Safety and Efficacy of TAC T Cells Targeting Claudin 18.2 in Solid Tumors

October 15, 2024
·
4 min read
Press Releases

Awakn Partners with the University of Nottingham for in Vivo Testing of Aminoindane New Chemical Entity (NCE) Pre-Clinical Program

October 15, 2024
·
7 min read
Press Releases

Biodexa Announces Successful Appeal of Nasdaq Delisting

October 15, 2024
·
4 min read
Press Releases

Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq

October 15, 2024
·
5 min read
Business

Endo to Host Investor Call on Third-Quarter 2024 Financial Results

October 15, 2024
·
1 min read